Form 4: Mangoceuticals President Receives 60,000 Shares as Discretionary Bonus

Antonios Isaac, President of Mangoceuticals, acquires 60,000 shares of common stock as a discretionary bonus for services rendered.

Summary

• Antonios Isaac, President of Mangoceuticals, acquired 60,000 shares of common stock on April 10, 2025.
• The shares were issued as a discretionary bonus in consideration for services rendered.
• The acquisition was made under the registrant's Second Amended and Restated 2022 Equity Incentive Plan and is exempt pursuant to Rule 16b-3.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard executive compensation disclosure. The bonus itself is a positive for the executive, but doesn't necessarily indicate overall company performance.

Positives

• The issuance of shares as a bonus may incentivize the President to further contribute to the company's success.

Industry Context

This type of equity compensation is common for executives, aligning their interests with shareholders.

Stakeholder Impact

• Shareholders may view this as a positive if it incentivizes management to improve company performance.

Key Dates

Keywords

Mangoceuticals, MGRX, Antonios Isaac, Form 4, Beneficial Ownership, Equity Incentive Plan, Bonus, Shares